关于开发具有广谱和持久免疫反应的流感疫苗会议报告，世界卫生组织，瑞士日内瓦，2004年2月26 - 27日。 - Suppr

Suppr

超能文献

Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004.

作者信息

Cassetti Maria Cristina, Couch Robert, Wood John, Pervikov Yuri

机构信息

Division of Microbiology and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

出版信息

Vaccine. 2005 Feb 18;23(13):1529-33. doi: 10.1016/j.vaccine.2004.09.004.

DOI:10.1016/j.vaccine.2004.09.004

PMID:15754468

Abstract

摘要

相似文献

Report of meeting on the development of influenza vaccines with broad spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 26-27 February 2004.

Vaccine. 2005 Feb 18;23(13):1529-33. doi: 10.1016/j.vaccine.2004.09.004.

Report of the third meeting on "influenza vaccines that induce broad spectrum and long-lasting immune responses", World Health Organization, Geneva, Switzerland, 3-4 December 2007.

Vaccine. 2008 May 12;26(20):2443-50. doi: 10.1016/j.vaccine.2008.03.006. Epub 2008 Mar 28.

Report of the 7th meeting on Evaluation of Pandemic Influenza Vaccines in Clinical Trials, World Health Organization, Geneva, 17-18 February 2011.

Vaccine. 2011 Oct 13;29(44):7579-86. doi: 10.1016/j.vaccine.2011.08.031. Epub 2011 Aug 19.

Report of the 5th meeting on the evaluation of pandemic influenza prototype vaccines in clinical trials: World Health Organization, Geneva, Switzerland, 12-13 February 2009.

Vaccine. 2009 Jun 24;27(31):4079-89. doi: 10.1016/j.vaccine.2009.04.059. Epub 2009 May 9.

Report of the 5th meeting on influenza vaccines that induce broad spectrum and long-lasting immune responses, World Health Organization, Geneva, 16-17 November 2011.

Vaccine. 2012 Oct 19;30(47):6612-22. doi: 10.1016/j.vaccine.2012.08.073. Epub 2012 Sep 11.

Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6-7 December 2005.

Vaccine. 2006 Jun 5;24(23):4897-4900. doi: 10.1016/j.vaccine.2006.03.035.

Report on the first WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Hong Kong SAR, China, 24-26 January 2013.

Vaccine. 2013 Aug 20;31(37):3766-71. doi: 10.1016/j.vaccine.2013.06.047. Epub 2013 Jun 27.

Report of the 4th meeting on the "Evaluation of pandemic influenza prototype vaccines in clinical trials." World Health Organization, Geneva, Switzerland, 14-15 February 2008.

Vaccine. 2008 Sep 15;26(39):4975-7. doi: 10.1016/j.vaccine.2008.04.050. Epub 2008 May 9.

Report of the 6th meeting on the evaluation of pandemic influenza vaccines in clinical trials World Health Organization, Geneva, Switzerland, 17-18 February 2010.

Vaccine. 2010 Oct 4;28(42):6811-20. doi: 10.1016/j.vaccine.2010.07.034. Epub 2010 Jul 25.

Complexities in assessing the effectiveness of inactivated influenza vaccines.

Euro Surveill. 2013 Feb 14;18(7):1.

引用本文的文献

Generation and testing anti-influenza human monoclonal antibodies in a new humanized mouse model (DRAGA: HLA-A2. HLA-DR4. Rag1 KO. IL-2Rγc KO. NOD).

Hum Vaccin Immunother. 2018 Feb 1;14(2):345-360. doi: 10.1080/21645515.2017.1403703. Epub 2017 Dec 21.

The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment.

PLoS One. 2014 Dec 10;9(12):e114637. doi: 10.1371/journal.pone.0114637. eCollection 2014.

A VLP vaccine induces broad-spectrum cross-protective antibody immunity against H5N1 and H1N1 subtypes of influenza A virus.

PLoS One. 2012;7(8):e42363. doi: 10.1371/journal.pone.0042363. Epub 2012 Aug 7.

The mucosal and systemic immune responses elicited by a chitosan-adjuvanted intranasal influenza H5N1 vaccine.

Influenza Other Respir Viruses. 2012 Mar;6(2):90-100. doi: 10.1111/j.1750-2659.2011.00271.x. Epub 2011 Jul 12.

Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.

PLoS One. 2009;4(5):e5538. doi: 10.1371/journal.pone.0005538. Epub 2009 May 14.

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers.

J Virol. 2006 May;80(10):4962-70. doi: 10.1128/JVI.80.10.4962-4970.2006.

A review of vaccine research and development: human acute respiratory infections.

Vaccine. 2005 Dec 30;23(50):5708-24. doi: 10.1016/j.vaccine.2005.07.046. Epub 2005 Aug 3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验